Experts explore strategies to support shared decision-making in the treatment of patients with tardive dyskinesia, ...

Neurocrine Biosciences shares new data supporting Ingrezza's effectiveness in older adults with tardive dyskinesia. Read more ...

The FDA has approved Neurocrine Bioscience’s Ingrezza, the first ever licensed treatment for tardive dyskinesia or TD. The condition is characterised by uncontrollable movement of the body or ...

Chris Eubank Jr. Vs. Conor Benn Weight: Middleweight (160 pounds). There is a hydration clause that prevents either man from weighing over 170 pounds on fight night. Eubank and Benn had been ...

Learn more about Xenazine's strengths and dosages. No, Xenazine isn’t approved to treat tardive dyskinesia. This is a condition that causes involuntary muscle movements, commonly in the face and ...

and akathisia – which is a neuropsychiatric syndrome of “psychomotor restlessness,” meaning the inability to remain physically still. According to The National Alliance on Mental Illness ...

Christoph U. Correll, MD, professor of psychiatry at The Zucker School of Medicine at Hofstra/Northwell and professor and chair of the department of child and adolescent psychiatry at Charité ...

movement disorders (tardive dyskinesia), and sedation, which can lead to people with schizophrenia rejecting treatment. In contrast, Cobenfy's side effects – typically gastrointestinal reactions ...

CNET staff -- not advertisers, partners or business interests -- determine how we review the products and services we cover. If you buy through our links, we may get paid. Originally hailing from ...

Credit cards and debit cards may seem like the same thing — after all they're both rectangular pieces of plastic — but they act quite differently. One card provides you with a revolving loan ...